In a new study, scientists show that the two-dose vaccination regimen of mRNA vaccines provides 88 percent protection against non-variant virus, 86 percent against the Alpha variant, and 77 percent against the Beta variant.
Click here for original story, Effectiveness of mRNA vaccines against the Alpha and Beta variants in France
Source: ScienceDaily